Funded Tech Companies
Orbis Medicines
Wondering who provided funding to Orbis Medicines? Eli Lilly and Company, EIFO and Forbion Capital Partners joined the equity holders in this innovative biopharmaceutical company.
Company Overview
Company Name
Orbis Medicines
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
Undisclosed
Copenhagen, Undisclosed
Denmark
Copenhagen, Undisclosed
Denmark
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
Our mission is to define a new era for macrocycle drugs and make great contributions to medicine. We are bringing together a world-class team to make this possible. Our broad pipeline is initially focused on delivering oral macrocycle candidates against targets validated by blockbuster biologic drugs.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
1/6/2025
Financing History
Management Team
Title
Name
Email & Social
Chairman
Morten Dossing
Chief Technical Officer
Sevan Habeshian
Vice President
Daniela Brodbeck
Vice President
Daniel Greve
VP - Bus. Development
Simon Feldbaek
Company Investors
- Eli Lilly and Company
- EIFO
- Forbion Capital Partners
- New Enterprise Associates
- Cormorant Capital
- Novo Holdings
Browse more funded tech companies:
Share this article
About Our VC Transaction Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs